Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis-Reference-Cited by-同舟云学术

Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis

Published:2017-11-22 Issue:1 Volume:17 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Olson Amy L.,Graney Bridget,Baird Susan,Churney Tara,Fier Kaitlin,Korn Marjorie,McCormick Mark,Sprunger David,Vierzba Thomas,Wamboldt Frederick S.,Swigris Jeffrey J.

Funder

Patient-Centered Outcomes Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-017-0497-0.pdf

Reference13 articles.

1. Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19.

2. Swigris JJ, Brown KK, Behr J, et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010;104:296–304.

3. Swigris JJ, Stewart AL, Gould MK, Wilson SR. Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61.

4. Belkin A, Albright K, Swigris J. A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Resp Res. 2013;1:e000007.

5. Nishiyama O, Taniguchi H, Kondoh Y, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005;99:408–14.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective, Descriptive Study of Dyspnea Management in a Multidisciplinary Interstitial Lung Disease Clinic;American Journal of Hospice and Palliative Medicine®;2022-04-28

2. Idiopathic Pulmonary Fibrosis-Treatment and Management;Encyclopedia of Respiratory Medicine;2022

3. Comprehensive Care of Interstitial Lung Disease;Encyclopedia of Respiratory Medicine;2022

4. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1;Pharmacological Research;2021-11

5. Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis;Contemporary Clinical Trials;2021-01